Glecirasib: KRAS G12C-mutated lung cancer: consultation records checklist

1. Provide pathology, staging and recent original CT images to identify lesions requiring attention
2. Bring the complete KRAS G12C report and sample information to confirm the variant
3. Organise dates and responses for previous chemotherapy, immunotherapy or targeted medicines to assess the basis for switching
4. Provide recent liver tests, blood counts and a list of prescription medicines and supplements to plan safety checks

Questions to clarify
- Do I meet the eligibility criteria?
- What are the separate medical and coordination service costs without Chinese health insurance or free-drug assistance?
- How are initial treatment, ongoing treatment, return travel and follow-up arranged?
- Which risks require immediate contact with the hospital?

An initial service consultation does not replace medical assessment.